Synthesis, ultra-short acting hypnotic activity, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a] [1,3]diazepin-3-carboxylate (HIE-124)

A.A. Kadi, H.A. El-Kashef, A.A.M. Abdel-Aziz, G. Hassan, J.N.A. Tettey, M.H. Grant, J. Lehmann, H.I. El-Subbagh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The synthesis and biological evaluation of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepin-3-carboxylate (HIE-124, 4), as a member of a new generation of ultra-short acting hypnotics is described. HIE-124 4 exhibited potent in-vivo activity with a very rapid onset of action and a shorter duration of action with no acute tolerance or noticeable side effects than thiopental sodium. The rat in-vivo and in-vitro metabolic profile of 4 is also described. Urine was pooled from a number of animals and analyzed using electrospray liquid chromatography mass spectrometry (ESI LC-MS). HIE-124 4 was incubated with rat-liver microsomal and rat-liver hepatocyte preparations then similarly analyzed. The only metabolic product of both in-vitro and in-vivo experiments is the carboxylic acid derivative 5. HIE-124 4 has the potential use not only as a pre-anesthetic medication and as anesthesia inducer but also has the potential to be used with thiopental sodium to maintain anesthesia for longer duration.
Original languageEnglish
JournalChemInform
Volume39
Issue number22
DOIs
Publication statusPublished - 27 May 2008

Keywords

  • multi-membered n-heterocycles
  • ring closure reactions
  • pharmacology
  • medicinal chemistry
  • vaccines
  • serums

Fingerprint Dive into the research topics of 'Synthesis, ultra-short acting hypnotic activity, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a] [1,3]diazepin-3-carboxylate (HIE-124)'. Together they form a unique fingerprint.

  • Cite this